These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28925359)

  • 1. Generation of an OCT4 reporter human induced pluripotent stem cell line using CRISPR/SpCas9.
    Balboa D; Weltner J; Novik Y; Eurola S; Wartiovaara K; Otonkoski T
    Stem Cell Res; 2017 Aug; 23():105-108. PubMed ID: 28925359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a SOX2 reporter human induced pluripotent stem cell line using CRISPR/SaCas9.
    Balboa D; Weltner J; Novik Y; Eurola S; Wartiovaara K; Otonkoski T
    Stem Cell Res; 2017 Jul; 22():16-19. PubMed ID: 28952927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of OCT4-EGFP, NANOG-tdTomato dual reporter human induced pluripotent stem cell line, KKUi001-A, using the CRISPR/Cas9 system.
    Lee M; Choi NY; Park S; Bang JS; Lee Y; Jeong D; Ham S; Lim S; Kim KH; Ko K
    Stem Cell Res; 2020 Oct; 48():101943. PubMed ID: 32777770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Knock-In Pigs Carrying Oct4-tdTomato Reporter through CRISPR/Cas9-Mediated Genome Engineering.
    Lai S; Wei S; Zhao B; Ouyang Z; Zhang Q; Fan N; Liu Z; Zhao Y; Yan Q; Zhou X; Li L; Xin J; Zeng Y; Lai L; Zou Q
    PLoS One; 2016; 11(1):e0146562. PubMed ID: 26756580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of TUBB3-mCherry knock-in human pluripotent stem cell line using CRISPR/Cas9 (SNUe003-A-4).
    Kim AH; Lee HM; Kim HS; Jung J; Seol H; Choi E; Lee S; Min Choi Y; Jun JK; Kim HS; Jang J
    Stem Cell Res; 2023 Jun; 69():103064. PubMed ID: 36913849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination.
    Wu J; Hunt SD; Xue H; Liu Y; Darabi R
    Sci Rep; 2016 Jan; 6():18759. PubMed ID: 26729410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
    Greder LV; Post J; Dutton JR
    Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a PXR reporter human induced pluripotent stem cell line (PXR-mCherry hiPSC) using the CRISPR/Cas9 system.
    Kim H; Kim JW; Kim SJ; Choi YJ; Kim DS; Park HJ
    Stem Cell Res; 2018 Jan; 26():72-75. PubMed ID: 29247817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
    Wu J; Hunt SD; Xue H; Liu Y; Darabi R
    Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
    Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
    Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a PDX1-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system.
    Lee Y; Choi HY; Kwon A; Park H; Park MH; Kim JW; Kim MJ; Kim YO; Kwak S; Koo SK
    Stem Cell Res; 2019 Dec; 41():101632. PubMed ID: 31683099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an OCT3/4 reporter cynomolgus monkey ES cell line using CRISPR/Cas9.
    Kobayashi K; Tsukiyama T; Nakaya M; Kageyama S; Tomita K; Murai R; Yoshida T; Narita M; Kawauchi A; Ema M
    Stem Cell Res; 2019 May; 37():101439. PubMed ID: 31005787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic tool for fate mapping of Oct4 (Pou5f1)-expressing cells and their progeny past the pluripotency stage.
    Kuzmin AA; Ermakova VV; Sinenko SA; Ponomartsev SV; Starkova TY; Skvortsova EV; Cherepanova O; Tomilin AN
    Stem Cell Res Ther; 2019 Dec; 10(1):391. PubMed ID: 31843009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear delivery of recombinant OCT4 by chitosan nanoparticles for transgene-free generation of protein-induced pluripotent stem cells.
    Tammam S; Malak P; Correa D; Rothfuss O; Azzazy HM; Lamprecht A; Schulze-Osthoff K
    Oncotarget; 2016 Jun; 7(25):37728-37739. PubMed ID: 27183911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.
    Marthaler AG; Adachi K; Tiemann U; Wu G; Sabour D; Velychko S; Kleiter I; Schöler HR; Tapia N
    Sci Rep; 2016 Jan; 6():19415. PubMed ID: 26762895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
    Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
    Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TALEN/CRISPR-mediated eGFP knock-in add-on at the OCT4 locus does not impact differentiation of human embryonic stem cells towards endoderm.
    Krentz NA; Nian C; Lynn FC
    PLoS One; 2014; 9(12):e114275. PubMed ID: 25474420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
    Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
    Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
    Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
    Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
    Desponts C; Ding S
    Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.